The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
Abstract SARS‐CoV‐2 interacting with its receptor, angiotensin‐converting enzyme 2 (ACE2), turns the host response to viral infection into a dysregulated uncontrolled inflammatory response. This is because ACE2 limits the production of the peptide angiotensin II (Ang II) and SARS‐CoV‐2, through the...
Saved in:
Main Authors: | Eugenie R. Lumbers (Author), Richard Head (Author), Gary R. Smith (Author), Sarah J. Delforce (Author), Bevyn Jarrott (Author), Jennifer H.Martin (Author), Kirsty G. Pringle (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment
by: Richard J. Head, et al.
Published: (2022) -
"LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy
by: Bevyn Jarrott, et al.
Published: (2022) -
Renin-Angiotensin Aldosterone System
Published: (2021) -
New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Overview of Regulation of the Renin-Angiotensin-Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010) -
The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020)